Resverlogix Corp. (TSE:RVX – Get Free Report) shares passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 1,300 shares changing hands.
Resverlogix Stock Performance
The stock has a market capitalization of C$30.11 million, a PE ratio of -3.17 and a beta of 0.26. The firm’s fifty day moving average is C$0.10 and its 200-day moving average is C$0.10. The company has a current ratio of 0.03, a quick ratio of 0.04 and a debt-to-equity ratio of -83.11.
Resverlogix (TSE:RVX – Get Free Report) last issued its quarterly earnings data on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share (EPS) for the quarter. As a group, research analysts anticipate that Resverlogix Corp. will post -0.22 earnings per share for the current year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
